Harnessing Monocytes for a Liposomal Rosiglitazone-Mediated Anti-Inflammatory Effect
<img src=" https://s3.amazonaws.com/production.scholastica/article/38312/large/prnano_842022.jpg?1663092842"> Rosiglitazone, an anti-diabetic drug used for treating type Ⅱ diabetes mellitus with known anti-inflammatory properties, was withdrawn from the European market. The United States Food and Dr...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Andover House Inc.
2022-09-01
|
| Series: | Precision Nanomedicine |
| Acceso en liña: | https://doi.org/10.33218/001c.38312 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|